|

Nikkei 225 stays firmer on Japan-Pfizer deal over covid vaccine supply

Early Friday morning, news broke that Japan’s Prime Minister Yoshihide Suga is ready to sign an agreement with Pfizer over the supply of the coronavirus (COVID-19) vaccines.

In doing so, the Asian major tries to tame the covid resurgence in areas surrounding Tokyo that signals the return of the virus-led activity restrictions.

Nikkei 225 remains mildly bid…

Nikkei 225 pays a little heed to otherwise trade-positive news. However, the risk barometer from Japan keeps 0.10% intraday gains by the press time. The reason for the equity gauge’s dismal reaction to the news could be traced from chatters over the Johnson & Johnson covid vaccine as well as geopolitical risks concerning China and Russia.

Read: S&P 500 Futures step back from record top as US Treasury yields pare weekly loss

Author

Anil Panchal

Anil Panchal

FXStreet

Anil Panchal has nearly 15 years of experience in tracking financial markets. With a keen interest in macroeconomics, Anil aptly tracks global news/updates and stays well-informed about the global financial moves and their implications.

More from Anil Panchal
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD remains below 1.1700 amid weakening momentum

EUR/USD remains steady after four days of losses, trading around 1.1680 during the Asian hours on Thursday. On the daily chart, the 14-day Relative Strength Index at 42.6 (neutral-bearish) indicates weakening momentum after slipping below the 50 midline. RSI staying sub-50 would keep bears engaged and limit recovery attempts.

GBP/USD consolidates above mid-1.3400s; bullish potential seems intact

The GBP/USD pair is seen consolidating its heavy losses registered over the past two days and oscillating in a narrow trading band, just above mid-1.3400s during the Asian session on Thursday. However, the fundamental backdrop warrants some caution for bearish traders and before positioning for an extension of the retracement slide from the 1.3565-1.3570 region, or the highest level since September 18, touched on Tuesday.

Gold: Deeper correction or dip-buying likely?

Gold is nursing losses near $4,450 in Asian trading on Thursday, having suffered about a 1% correction from weekly highs of $4,500 on Wednesday. All eyes remain on the geopolitical developments and the incoming US jobless claims data for fresh trading directives.

Top Crypto Losers: Pump.fun, Story, and Pudgy Penguins test key support levels

Pump.fun, Story, and Pudgy Penguins experience intense selling pressure over the last 24 hours. PUMP and IP failed to cross the 50-day Exponential Moving Average, resulting in a pullback on Wednesday, while PENGU is testing its 50-day EMA.

2026 economic outlook: Clear skies but don’t unfasten your seatbelts yet

Most years fade into the background as soon as a new one starts. Not 2025: a year of epochal shifts, in which the macroeconomy was the dog that did not bark. What to expect in 2026? The shocks of 2025 will not be undone, but neither will they be repeated.

XRP battles selling pressure as profit-taking, ETF inflows shape outlook

Ripple (XRP) is trading downward but holding support at $2.22 at the time of writing on Wednesday, as fear spreads across the cryptocurrency market, reversing gains made from the start of the year.